The impact of mitochondrial quality control by Sirtuins on the treatment of type 2 diabetes and diabetic kidney disease

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Jing XuDaisuke Koya

Abstract

The incidence of type 2 diabetes mellitus (T2DM) and diabetic kidney disease (DKD) has significantly increased worldwide in recent decades, and improved treatments for T2DM and DKD are urgently needed. The pathogenesis of aging-related disorders, such as T2DM and DKD, involves multiple mechanisms, including inflammation, autophagy impairment, and oxidative stress, which are closely associated with mitochondrial dysfunction. Therefore, mitochondrial quality control may be a novel therapeutic target for T2DM and DKD. Previous reports have shown that members of the mammalian Sirtuin family, SIRT 1-7, which are recognized as antiaging molecules, play a crucial role in the regulation of mitochondrial function and quality control through the modulation of oxidative stress, inflammation and autophagy. In this review, we summarized the research published in recent years to highlight the role of Sirtuins in mitochondrial quality control as a therapeutic target for T2DM and DKD.

References

Nov 29, 2002·The EMBO Journal·Lin-feng ChenWarner C Greene
Apr 17, 2003·Molecular and Cellular Biology·Sylvia C DrydenMichael A Tainsky
Feb 13, 2004·The New England Journal of Medicine·Kitt Falk PetersenGerald I Shulman
Jan 22, 2005·Science·Bradford B Lowell, Gerald I Shulman
Mar 30, 2005·The Journal of Biological Chemistry·Gregory LisztLeonard Guarente
May 3, 2005·The Journal of Clinical Investigation·Kathryn E Wellen, Gökhan S Hotamisligil
Aug 2, 2005·Cell Metabolism·Jiandie LinBruce M Spiegelman
Jan 28, 2006·Cell·Raul MostoslavskyFrederick W Alt
Apr 19, 2006·Genes & Development·Ethan FordLeonard Guarente
May 2, 2006·Genes & Development·Alejandro VaqueroDanny Reinberg
Jun 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bjoern SchwerEric Verdin
Nov 3, 2006·Genes & Development·Marcia C Haigis, Leonard P Guarente
Jan 2, 2007·The Journal of Biological Chemistry·Masaya TannoYoshiyuki Horio
Mar 10, 2007·The EMBO Journal·Zachary Gerhart-HinesPere Puigserver
Aug 24, 2007·The Journal of Biological Chemistry·Nidhi AhujaEric Verdin
Oct 10, 2007·Molecular and Cellular Biology·David B LombardBjoern Schwer
Feb 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·In Hye LeeToren Finkel
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Bong-Hyun AhnToren Finkel
Dec 24, 2008·Molecular and Cellular Biology·Takeshi YoshizakiJerrold M Olefsky
May 16, 2009·Journal of the American Society of Nephrology : JASN·Toshiharu NinomiyaUNKNOWN ADVANCE Collaborative Group
Sep 22, 2009·Biochimica Et Biophysica Acta·Melanie Gertz, Clemens Steegborn
Oct 10, 2009·Pharmacological Reports : PR·Sandip Patel, Dev Santani
Dec 10, 2009·American Journal of Physiology. Endocrinology and Metabolism·Takeshi YoshizakiJerrold M Olefsky
Jan 26, 2010·Biochemical and Biophysical Research Communications·Masahito OguraNobuya Inagaki
Aug 6, 2010·The Journal of Biological Chemistry·Nargis NasrinLaura Bordone

❮ Previous
Next ❯

Citations

Aug 8, 2020·Frontiers in Physiology·Munehiro KitadaDaisuke Koya
May 4, 2021·Frontiers in Cell and Developmental Biology·Jing XuDaisuke Koya
Aug 10, 2021·Frontiers in Medicine·Jing XuDaisuke Koya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms